Step Pharma is developing a novel class of oral nucleotide synthesis inhibitors specifically targeting cytidine triphosphate synthase 1 (CTPS1) to induce selective modulation of T and B cell populations. 

Biotechnology

Step Pharma

Step Pharma's headquarters in Archamps, France

Andrew Parker

Vanessa Cogan

Brian Schwartz

Thien Duc Tran

Philip Beer

Duc Tran

Nicolas Marsault

Thibaut Roulon

Ohad Hammer

Erik Van Den Berg

Walter Stockinger

Alain Fischer

Adrian Senderowicz

Steven M. Horwitz

Iain McInnes

Tim Wright

Christophe Benoist

Jean-Pierre Bizzari

Kapil Dhingra

Stephen M. Ansell

Vanessa Malier

Simon Hirst

The Financial and Development Team at Step Pharma is responsible for overseeing the strategic allocation of financial resources and ensuring the successful development of novel nucleotide synthesis inhibitors. This team collaborates closely with research and clinical departments to manage budgets, assess financial viability, and drive the progression of therapies targeting CTPS1, while also providing leadership in financial planning and operational execution to support the company’s long-term goals.

Financial and Development Team

The Scientific Advisory Team at Step Pharma plays a critical role in guiding research and development efforts for the company’s innovative nucleotide synthesis inhibitors targeting CTPS1. Comprising leading experts, including scientific founders and advisors, the team provides strategic oversight, ensures scientific rigor, and helps shape the therapeutic direction, facilitating the translation of cutting-edge research into effective treatments for modulating T and B cell populations.

Scientific Advisory Team

The Clinical Operations Team at Step Pharma is responsible for the strategic planning, execution, and oversight of clinical trials for the company's novel nucleotide synthesis inhibitors. The team works closely with clinical advisors and project managers to ensure regulatory compliance, optimize trial protocols, and manage timelines and budgets, ultimately advancing the development of therapies targeting T and B cell populations.

Clinical Operations Team

The Leadership Team at Step Pharma is responsible for defining the strategic vision and direction of the company, overseeing the development and commercialization of its novel nucleotide synthesis inhibitors. They collaborate to align scientific research with business objectives, manage financial resources, and foster innovation, ensuring that the therapy effectively targets immune modulation in T and B cell populations. Their combined expertise drives the company's mission to revolutionize treatment options in immunology.

Leadership Team

Step Pharma

Org chart

Board & advisors

Teams

Financial and Development Team

Scientific Advisory Team

Clinical Operations Team

Leadership Team

Offices

Step Pharma

Org chart

Board & advisors

Teams

Financial and Development Team

Scientific Advisory Team

Clinical Operations Team

Leadership Team

Offices

Related companies